Read + Share
Byun JY, Kim J, Park S, Sun JM, et al. A matching-adjusted indirect comparison of first-line lorlatinib and alectinib
for the treatment of ALK-rearranged advanced non-small cell lung cancer. Eur J Cancer 2025;230:115805.
PMID: 41014855
|
 |
|
Byun JY, Kim J, Park S, Sun JM, et al. A matching-adjusted indirect comparison of first-line lorlatinib and alectinib
for the treatment of ALK-rearranged advanced non-small cell lung cancer. Eur J Cancer 2025;230:115805.
PMID: 41014855
|
|
|
|